Chemotherapies are extremely toxic and the can interfere with our immune systems, the systems that help us fight off cancer in the first place. Centrose is developing non-toxic targeted therapies that work with our immune systems, not against them.
Centrose is developing targeted drugs called EDCs that focus on killing cancer cells while potentiating the immune system. Centrose does this by attaching highly evolved steroidal drugs to antibodies. The antibodies allow for direct delivery of the steroid only to cancer cells. Once EDCs attach to cancer cells, the cells are programmed to stop growing and to recruit immune effector cells to destroy them.
The most advanced therapeutic platform to date, EDCs represent a new paradigm in drug safety and efficacy.